News
Integration of clinical and patient-reported outcomes expected to further differentiate EluPro’s utility in cardiac implantable electronic ...
Elutia’s Roswell facility is FDA-registered as a medical device manufacturing establishment and has not experienced any delays, cost increases, or supplier issues related to the tariffs. The Company ...
Elutia to Participate in Chardan’s Trending Issues in Drug Development Conference Series on April 29
Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a pioneer in drug-eluting biomatrix technologies, today announced that Michelle LeRoux Williams, Ph.D., Elutia’s Chief Scientific Officer, will participate in ...
Hosted on MSN26d
Elutia Inc. secures $15 million through stock and warrant saleSILVER SPRING, Md. - Elutia Inc. (NASDAQ:ELUT), a medical technology company with a current market capitalization of $111.29 million according to InvestingPro, disclosed today that it has ...
Elutia Inc. has announced the launch of a clinical study for EluPro™, the first FDA-cleared antibiotic-eluting bioenvelope designed for use with cardiac implantable electronic devices (CIEDs).
SILVER SPRING, Md., April 02, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix products, is proud to announce the debut ...
Elutia management will also participate in 1x1 investor meetings. Institutional investors interested in scheduling a meeting may contact an LD Micro or Planet Microcap representative or email IR@ ...
Elutia to Participate in Chardan’s Trending Issues in Drug Development Conference Series on April 29
SILVER SPRING, Md., April 22, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a pioneer in drug-eluting biomatrix technologies, today announced that Michelle LeRoux Williams ...
SILVER SPRING, Md., April 14, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix products, today confirmed that the ...
Elutia To Participate In Chardan’S Trending Issues In Drug Development Conference Series On April 29
A live and archived webcast of the fireside chat will be available in the“Investors” section of the Elutia website at . Elutia develops and commercializes drug-eluting biomatrix products to ...
Elutia to Participate in Chardan’s Trending Issues in Drug Development Conference Series on April 29
A live and archived webcast of the fireside chat will be available in the “Investors” section of the Elutia website at http://investors.elutia.com/. About Elutia ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results